Berdagang MerckCo USA MRK

Jual
 Beli

MerckCo carta live

5m 15m 30m 1h 4h 1d 1w

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

MerckCo news

Big Tech, Apple, Meta, Microsoft, Amazon & Alphabet
Neil Wilson 2024 Oct 24, 16:00

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Forex Indices
Bank of England, BoJ, Fed all hold policy meetings this week
Georgy Istigechev 2024 Jul 25, 16:00

Week ahead: Eurozone inflation, Fed meeting, Apple earnings

Forex Indices
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
The Bank of England
Neil Wilson 2024 Jan 25, 08:03

Week ahead: Fed, BoE to hold; Apple leads big tech earnings

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares

Berita Terkini

Tunjukkan lebih lagi
N/A
Noah Lee 2025 Jul 03, 08:35

Wall Street Strategist: Potential $100B+ Stock Market Influx Coming

N/A
Sophia Claire 2025 Jul 03, 08:35

Euro Surges in Foreign Exchange Options Market Amid Bullish Sentiment

N/A
Emma Rose 2025 Jul 03, 08:35

AI Podcast: The Pennsylvania Plan - Domestic Investors to the Rescue?

N/A
liam james 2025 Jul 03, 08:35

AI Podcast: Dollar Weakens Amid Fed Chair Uncertainty

N/A
liam james 2025 Jul 03, 08:35

JPMorgan Model Predicts Stock Market Upswing: An AI Podcast Breakdown

N/A
Ava Grace 2025 Jul 03, 08:35

Dollar Index Plummets Amid Fed Independence Concerns

N/A
liam james 2025 Jul 03, 07:35

AI Podcast: Decoding Economic Indicators and Fed Policy

N/A
Sophia Claire 2025 Jul 03, 07:35

AI Podcast: S&P 500 Hits Record High, Sparking Market Bubble Fears

Maklumat

Sebaran nilai

0.49

Spread (%)

0.6071 %

Leveraj

1:10

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran ditutup

Isnin

13:31 - 19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Khamis

13:31-16:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

206883766272

Saham Tertunggak

2511030016

Tarikh Pendapatan (Seterusnya)

2021-06-03

Hasil Div

2025-07-08

Tarikh Selepas Dividen

2025-06-16

Kadar dividen tahunan depan

3.24

Hasil dividen tahunan depan

0.0409

EPS

6.88

Ketahui lebih lanjut mengenai instrumen ini

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and ant

Instrumen Berkaitan

Aset
Jual
Beli
Perubahan (%):

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang
Instrumen Berkaitan

latest_education_articles

Tunjukkan lebih lagi
Trustpilot